First-trimester drug use and congenital disorders
- 24 July 1981
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 246 (4), 343-346
- https://doi.org/10.1001/jama.246.4.343
Abstract
The prevalence of certain major congenital disorders among the infants of women who used a wide variety of drugs during the 1st trimester of pregnancy were determined in a prepaid health plan in which automated recording of prescriptions filled and disorders diagnosed at birth was available. No strong associations between any of the commonly used drugs and congenital disorders studied were present.This publication has 8 references indexed in Scilit:
- REPLACEMENT ESTROGENS AND BREAST CANCER1American Journal of Epidemiology, 1980
- ORAL CONTRACEPTIVES AND BREAST CANCER1American Journal of Epidemiology, 1980
- EXOGENOUS HORMONES AND OTHER DRUG EXPOSURES OF CHILDREN WITH CONGENITAL HEART DISEASE1American Journal of Epidemiology, 1979
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Teratogenicity testing in humans: A method demonstrating safety of BendectinTeratology, 1978
- Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Bendectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient scoreAmerican Journal of Obstetrics and Gynecology, 1977
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- An evaluation of the teratogenicity of certain antinauseant drugsAmerican Journal of Obstetrics and Gynecology, 1976